4569 — Kyorin Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥105bn
- ¥107bn
- ¥113bn
- 63
- 60
- 75
- 79
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9,359 | 8,255 | 8,352 | 5,216 | 6,906 |
Depreciation | |||||
Non-Cash Items | -631 | -363 | -2,432 | 405 | -1,483 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11,327 | -3,435 | -4,297 | -2,988 | -7,339 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 341 | 7,678 | 5,187 | 6,347 | 1,924 |
Capital Expenditures | -4,369 | -3,217 | -5,124 | -2,690 | -9,405 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 19,308 | 274 | 865 | 130 | 3,130 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 14,939 | -2,943 | -4,259 | -2,560 | -6,275 |
Financing Cash Flow Items | — | -1 | -1 | -2 | -1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -27,315 | -5,117 | -4,918 | -4,112 | -3,363 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -12,057 | -404 | -4,033 | -186 | -7,473 |